Thomas Maldonado, MD
Vascular Surgery · New York, NYNPI 1477547206
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.6%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 22.3%. Among vascular surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 495 payments — averaging $503.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Incorporated$56K
- W. L. Gore & Associates, Inc.$46K
- Penumbra, Inc.$44K
- Silk Road Medical, Inc.$30K
- Tactile Systems Technology Inc$21K
- Endologix LLC$20K
- plus $32K from 24 others
Across 189 payments — averaging $4115.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Tactile Systems Technology Inc$391K
- Medtronic$122K
- Penumbra, Inc.$83K
- Inari Medical, Inc.$82K
- Cook Research Incorporated$60K
- Silk Road Medical, Inc.$34K
- plus $6K from 1 others
What the payments were for
- Consulting fees$123,45550%
- Speaking & faculty fees$87,66035%
- Travel & lodging$16,0846%
- Food & beverage$21,7969%
- Education$240%
- Entertainment$620%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Incorporated | 23 | $55,583 |
| W. L. Gore & Associates, Inc. | 90 | $46,466 |
| Penumbra, Inc. | 33 | $43,952 |
| Silk Road Medical, Inc. | 28 | $29,513 |
| Tactile Systems Technology Inc | 63 | $21,450 |
| Endologix LLC | 39 | $19,707 |
| Medtronic(2 entities) | 58 | $13,907 |
| Shape Memory Medical Inc. | 5 | $5,696 |
| Cook Medical LLC | 82 | $5,321 |
| Bolton Medical Inc | 22 | $4,563 |
| Inari Medical, Inc. | 20 | $1,333 |
| Cook Research Incorporated | 2 | $412 |
| Bard Peripheral Vascular, Inc. | 2 | $171 |
| Artivion, Inc. | 2 | $150 |
| Baxter Healthcare | 5 | $144 |
| Cvrx, Inc. | 1 | $122 |
| Abbott | 1 | $89 |
| Boston Scientific | 2 | $72 |
| Inspiremd Ltd | 1 | $68 |
| Terumo Medical Corporation | 2 | $67 |
| Johnson & Johnson | 4 | $59 |
| Surmodics, Inc. | 1 | $48 |
| Angiodynamics, Inc. | 1 | $41 |
| E.r. Squibb & Sons, L.L.C. | 2 | $41 |
| Neuros Medical, Inc. | 1 | $28 |
| Smith+Nephew | 1 | $23 |
| Pfizer | 1 | $22 |
| Lemaitre Vascular, Inc. | 1 | $17 |
| KCI USA, Inc. | 1 | $13 |
| Cardiovascular Systems Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$39,685
- ENROUTE Transcarotid Neuroprotection System$35,363
- ENROUTE Transcarotid Stent$25,640
- GORE EXCLUDER AAA Endoprosthesis$20,227
- Product in Development$19,257
- ENTRE$19,251
- Cook Medical Zenith$19,168
- GORE EXCLUDER Iliac Branch Endoprosthesis$18,620
- GORE TAG Conformable Thoracic Endoprosthesis$17,275
- FLEXITOUCH$13,641
- ACTITOUCH$13,641
- ENHANCE Transcarotid Peripheral Access Kit$13,010
- Zenith$9,422
- ENROUTE .014 Guidewire$9,405
- ENDURANT IIS$9,343
- Cook$8,660
- Zenith Spiral-Z$7,564
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$6,118
- Flexitouch Plus$5,610
- IMPEDE EMBOLIZATION PLUG$5,602
How this compares
$249,081 in reported general payments places this provider in the 95th percentile of 405 vascular surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 51 | $38,576 |
| BrilintaTicagrelor | 21 | $16,367 |
| EliquisApixaban | 11 | $8,724 |
| ClopidogrelClopidogrel Bisulfate | 101 | $1,167 |
| Cilostazol | 16 | $307 |
| Prednisone | 11 | $11 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $59 | $38,57651 claims |
| PfizerEliquis | $22 | $8,72411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 405 vascular surgery providers in New York.
Other vascular surgery in New York
- Gary GelbfishNew York$1.9M
- John LantisNew York$922K
- Brian DerubertisNew York$714K
- James McKinseyNew York$616K
- Peter FariesNew York$494K
- Ajit RaoNew York$294K
- Daniel HanNew York$280K
- Todd BerlandNew York$260K
- Karan GargNew York$246K
- Rami TadrosNew York$218K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.